Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy

Clinical Cancer Research

Volumn 8, Issue 11, 2002, Pages 3570-3578

  Li, Mengfeng ^a   Ye, Caisheng ^a,b   Feng, Chong ^a,b   Riedel, Frank ^a   Liu, Xiaoning ^a   Zeng, Qing ^a   Grandis, Jennifer Rubin ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 ((3 BROMOPHENYL)AMINO) 6,7 DIMETHOXYQUINAZOLINE; 4-((3-BROMOPHENYL)AMINO)-6,7-DIMETHOXYQUINAZOLINE; ANTISENSE OLIGONUCLEOTIDE; COLLAGEN; ENDOSTATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LIPOSOME; PEPTIDE FRAGMENT; QUINAZOLINE DERIVATIVE; RECOMBINANT PROTEIN; ANGIOGENESIS INHIBITOR; VASCULOTROPIN;

ANIMAL; ARTICLE; C3H MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; CYTOLOGY; DOWN REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PLASMID; SQUAMOUS CELL CARCINOMA; TIME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION; WESTERN BLOTTING; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL CULTURE; CONTROLLED STUDY; GENE THERAPY; HEAD AND NECK CARCINOMA; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELLS, CULTURED; COLLAGEN; DOWN-REGULATION; ENDOSTATINS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSOMES; MICE; MICE, INBRED C3H; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE FRAGMENTS; PLASMIDS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 0036847719     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Folkman, J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995
2. O'Reilly, M., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W., Flynn, E., Birkhead, J., Olsen, B., and Folkman, J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997
3. O'Reilly, M., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R., Moses, M., Lane, W., Cao, Y., Sage, E., and Folkman, J. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994
4. O'Reilly, M., Pirie-Shepherd, S., Lane, W., and Folkman, J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science (Wash. DC), 285: 1926-1928, 1999
5. Herbst, R. S., Kenneth, R., Tran, H. T., Tseng, J. E., Mullani, N. A., Charnsangavej, C., Madden, T., Davis, D. W., McConkey, D. J., O'Reilly, M. S., Ellis, I. M., Pluda, J., Hong, W. K., and Abbruzzese, J. I., Phase I study of recombinant human endostatin in patients with advanced solid tumors, J. Clin. Oncol., 15: 3792-3803, 2002
6. Wells, A. EGF receptor. Int. J. Biochem. Cell Biol., 31: 637-643, 1999
7. Turner, T., Chen, P., Goodly, L. J., and Wells, A. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin. Exp. Metastasis, 14: 409-418, 1996
8. Khazaie, K., Schirrmacher, V., and Lichtner, R. B. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev., 12: 255-274, 1993
9. Goldman, C. K., Kim, J., Wong, W. L., King, V., Brock, T., and Gillespie, G. Y. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell, 4: 121-133, 1993
10. Salomon, D. S., Brandt, R., Ciardiello, F., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol/Haematol., 19: 183-232, 1995
11. Woodburn, J. R. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol. Ther., 82: 241-250, 1999
12. Shin, D. M., Donato, N. J., Perez-Soler, R., Shin, H. J., Wu, J. Y., Zhang, P., Lawhorn, K., Khuri, F. R., Glisson, B. S., Myers, J., Clayman, G., Pfister, D., Falcey, J., Waksal, H., Mendelsohn, J., and Hong, W. K. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin. Cancer Res., 7: 1204-1213, 2001
13. He, Y., Zeng, Q., Drenning, S. D., Melhem, M. F., Tweardy, D. J., Huang, L., and Grandis, J. R. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J. Natl. Cancer Inst., 90: 1080-1087, 1998
14. Sacks, P. G., Oke, V., Amos, B., Vasey, T., and Lotan, R. Modulation of growth, differentiation and glycoprotein synthesis by βall-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int. J. Cancer, 44: 926-933, 1989
15. Grandis, J. R., and Tweardy, D. J. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res., 53: 3579-3584, 1993
16. Huang, X., Wong, M. K. K., Zhao, Q., Zhu, Z., Wang, K. Z. Q., Huang, N., Ye, C., Gorelik, E., and Li, M. Soluble recombinant endostatin purified from Escherichia coli: Antiangiogenic activity and antitumor effect. Cancer Res., 61: 478-481, 2001
17. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991
18. Witters, L., Kumar, R., Mandal, M., Bennet, C. F., Miraglia, L., and Lipton, A., Antisense oligonucleotides to the epidermal growth factor receptor. Breast Cancer Res. Treat., 53: 41-50, 1999
19. Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G., and Low, P. S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Sci. USA, 92: 3318-3322, 1995
20. Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., and Bridges, A. J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Wash. DC), 65: 1093-1095, 1994
21. Grandis, J. R., Chakraborty, A., Melhem, M. F., Zeng, Q., and Tweardy, D. J. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene, 15: 409-416, 1997
22. Li, M., Huang, X., Zhu, Z., Wong, M., Watkins, S., Zhao, Q., Herberman, R., and Gorelik, E. Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin. J. Immunother., 24: 472-481, 2001
23. Detmar, M. Tumor angiogenesis. J. Investig. Dermatol. Symp. Proc., 5: 20-23, 2000
24. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. Vascular-specific growth factors and blood vessel formation. Nature (Lond.), 407: 242-248, 2000
25. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Anti angiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997
26. Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Pomatico, G., De Placido, S., Bianco, A. R., and Tortora, G. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin. Cancer Res., 6: 2053-2063, 2000
27. Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Fontanini, G., Cuccato, S., De Placido, S., Bianco, A. R., and Tortora, G. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin. Cancer Res., 1459-1465, 2001
28. Bruns, C. J., Solorzano, C. C., Harbison, M. T., Ozawa, S., Tsan, R., Fan, D., Abbruzzese, J., Traxler, P., Buchdunger, E., Radinsky, R., and Fidler, I. J. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res., 60: 2926-2935, 2000
29. Solorzano, C. C., Baker, C. H., Tsan, R., Traxler, P., Cohen, P., Buchdunger, E., Killion, J. J., and Fidler, I. J. Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. Clin. Cancer Res., 7: 2563-2572, 2001
30. Rak, J., Yu, J. L., Klement, G., and Kerbel, R. S. Oncogenes and angiogenesis: Signaling three-dimensional tumor growth. J. Investig. Dermatol. Symp. Proc., 5: 24-33, 2000
31. Schreiber, A. B., Winkler, M. E., and Derynck, R. Transforming growth factor-α: A more potent angiogenic mediator than epidermal growth factor. Science (Wash. DC), 232: 1250-1253, 1986
32. Shiurba, R. A., Eng, L. F., Vogel, H., Lee, Y. L., Horoupian, D. S., and Urich, H, Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells. Cancer (Phila.), 62: 2139-2144, 1988